Turkish Journal of Biology
Volume 40

Number 2

Article 16

1-1-2016

Role of melatonin on differentiation of mesenchymal stem cells
derived from third molar germ tissue
NURULLAH AYDOĞDU
PAKİZE NESLİHAN TAŞLI
HATİCE BURCU ŞİŞLİ
MEHMET EMİR YALVAÇ
FİKRETTİN ŞAHİN

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
AYDOĞDU, NURULLAH; TAŞLI, PAKİZE NESLİHAN; ŞİŞLİ, HATİCE BURCU; YALVAÇ, MEHMET EMİR; and
ŞAHİN, FİKRETTİN (2016) "Role of melatonin on differentiation of mesenchymal stem cells derived from
third molar germ tissue," Turkish Journal of Biology: Vol. 40: No. 2, Article 16. https://doi.org/10.3906/
biy-1502-52
Available at: https://journals.tubitak.gov.tr/biology/vol40/iss2/16

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Biology
http://journals.tubitak.gov.tr/biology/

Research Article

Turk J Biol
(2016) 40: 430-442
© TÜBİTAK
doi:10.3906/biy-1502-52

Role of melatonin on differentiation of mesenchymal stem cells
derived from third molar germ tissue
1

2

2

3

2,

Nurullah AYDOĞDU , Pakize Neslihan TAŞLI , Hatice Burcu ŞİŞLİ , Mehmet Emir YALVAÇ , Fikrettin ŞAHİN *
1
Institute for Molecular Biology, Hannover Medical School, Hannover, Germany
2
Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, 26 Ağustos Campus,
İstanbul, Turkey
3
Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA
Received: 27.02.2015

Accepted/Published Online: 13.09.2015

Final Version: 23.02.2016

Abstract: Stem cell-based applications have become a popular and promising approach for therapy for a number of disorders including
neurodegenerative diseases, degenerative muscle diseases, and osteoporosis, as well as trauma, inflammations, burns, and injuries.
Human tooth germ stem cells are an adult stem cell source; they have mesenchymal stem cell properties and show high proliferative and
differentiation capacity. Melatonin has been demonstrated to regulate differentiation of human and mouse mesenchymal stem cells into
various cell lineages in addition to its other functions in the body. In the current study, the effects of melatonin on osteogenic, neurogenic,
adipogenic, chondrogenic, myogenic, and odontogenic differentiation of human tooth germ stem cells were investigated. The results
showed that melatonin increases the viability of cells. It significantly augments osteogenic, neurogenic, chondrogenic, myogenic, and
odontogenic differentiation of the cells, whereas it reduces adipogenic differentiation capability. These results suggest that melatonin
has a great potential to increase differentiation capacity of human tooth germ stem cells and might be useful in regenerative therapy
applications involving stem cell differentiations in addition to defining potential treatments for obesity because of its suppressor effects
on adipogenesis.
Key words: Neurogenesis, odontogenesis, adipogenesis, chondrogenesis, myogenesis, human tooth germ stem cells, melatonin

1. Introduction
Melatonin, also known as N-acetyl-5-methoxytryptamine,
is an indole amine produced and released by the pineal
gland mainly during the dark phase of the light/dark cycle
(Bubenik, 2008). It is also produced in many other tissues
but it is not released to the blood from these sites (Jarzynka
et al., 2009). Melatonin has been found to be involved in a
number of processes, including circadian rhythm, tumor
growth inhibition, immune response, and reproduction, as
well as scavenging of free radicals. Moreover, metabolites
of melatonin are also highly effective radical scavengers
(Galano et al., 2013).
Melatonin regulates the differentiation of stem cells.
It enhances osteogenic differentiation of several cell
types such as human osteoblasts, human mesenchymal
stem cells (hMSCs), human bone cells, and MC3T3-E1
preosteoblast and rat osteoblast-like osteosarcoma 17/2.8
cells, as well as bone formation and growth in mice (Roth
et al., 1999; Satomura et al., 2007; Zhang et al., 2010).
Melatonin enhances cartilage matrix synthesis as well
as the expression of chondrogenic markers including
* Correspondence: fsahin@yeditepe.edu.tr
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collagen II, Sox 9, and aggrecan of porcine articular
chondrocytes. Recently, it was found that it increases
chondrogenic differentiation of hMSCs (Pei et al., 2009).
In contrast to osteogenesis and chondrogenesis, melatonin
has been reported to inhibit adipogenic differentiation
of hMSCs. It inhibits triglyceride accumulation in rat
osteoblast-like ROS17/2.8 cells as well as increasing
the expression of leptin in rat adipocytes (Brydon et
al., 2001). Additionally, in vivo, reduced lipolysis and
increased lipogenesis were found in pinealectomized rats,
mimicked by the withdrawal of melatonin (Borges-Silva
et al., 2005). Although melatonin’s effect on osteogenic,
chondrogenic, and adipogenic differentiations has been
described, data regarding the effects of melatonin on
other cell functions such as neurogenesis, myogenesis,
and odontogenesis are limited or not known. Melatonin
concentrations have a modulatory effect on both selfrenewal and neural differentiation of neural stem cells
(Moriya et al., 2007). In addition, it stimulates neural stem
cells to differentiate into dopaminergic neurons in rats
(Kong et al., 2008). Melatonin plays a protective role on
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the survival of myocytes against damage by doxorubicin
and reduces the hypoxic damage in cardiomyocytes (Salie
et al., 2001; Xu and Ashraf, 2002). Although melatonin’s
effect on odontogenesis remains unclear, it is likely to have
an important role in tooth development since melatonin
receptor MT1 has been found in the tooth germs of human
and mice (Kumasaka et al., 2010).
Human tooth germ stem cells (hTGSCs) are
mesenchymal stem cells with high proliferation and
differentiation capacity that are derived from human third
molar tooth germs of young individuals (Yalvac et al.,
2010). Besides their availability in adults and the lack of
ethical issues, hTGSCs can be converted into osteogenic,
adipogenic, and odontogenic cells (Gronthos et al.,
2002; Güven et al., 2013; Taşlı and Şahin, 2014) and also
endothelial linages (Doğan et al., 2015).
In the present study, the effect of melatonin on
osteo-, chondro-, adipo-, neuro-, myo-, and odontogenic
differentiation of hTGSCs was evaluated. The aim of this
study was to identify the role of melatonin on various
differentiations of hTGSCs and to provide additional
evidence for the use of melatonin as a drug in regenerative
medicine.
2. Materials and methods
2.1. Isolation and culture conditions of hTGSCs
Human tooth germs were collected from the third molar
teeth of patients 14–18 years old. The collected tooth germs
were harvested and minced (Taşlı et al., 2014, 2015). The
tooth germ tissue was plated in six-well plates (BIOFIL,
TCP, Switzerland) and grown to confluency in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal bovine serum (FBS) and 1% (v/v) prostatespecific antigen (PSA) (10,000 units/mL penicillin,
10,000 µg/mL streptomycin, 25 µg/mL amphotericin B)
(Invitrogen, GIBCO, UK). The harvested cells expanded
and started to appear after 3–4 days, and they covered the
surface after 8 days. Thereafter, the cells were trypsinized
using 0.25% (v/v) trypsin/EDTA (Invitrogen, GIBCO).
Medium was added to detached cells to inhibit the activity
of trypsin. After the cells were centrifuged at 300 × g for 5
min at room temperature, the pellet was dissolved in fresh
medium and seeded in a T-75 flask (Zelkultur Flaschen,
Switzerland). The cells were maintained at 37 °C and 5%
CO2 in a humidified incubator. Cells from passages 3–4
were used in all experiments.
2.2. Characterization of hTGSCs
The procedure for characterization of hTGSCs was
previously published by our group (Yalvac et al.,
2010). Cells were trypsinized and incubated with the
primary antibodies, which were prepared in PBS. For
characterization, primary antibodies against CD29,
CD34, CD45, CD90, CD105, CD133, CD166 (Santa Cruz

Biotechnology Inc., USA), and CD73 (Zymed, USA)
were used. The cells were washed with PBS to remove
the excess primary antibodies. Thereafter, the cells were
incubated with fluorescein-isothiocyanate (FITC)conjugated secondary antibody at 4 °C for 1 h except for
CD29, for which phycoerythrin (PE)-red light-harvesting
protein containing chromophore-conjugated monoclonal
antibody was used. The flow cytometry analysis of the
cells was performed by using the Becton Dickinson
FACSCalibur flow cytometry system (Becton Dickinson,
USA).
2.3. MTS Assay
Melatonin (MP Biomedicals LLC, USA) at different
concentrations (50 nM, 100 nM, and 150 nM) was prepared
in DMEM with 10% (v/v) FBS and 1% (v/v) PSA. Cells
were seeded on a 96-well plate (BIOFIL, TCP, Switzerland)
at a density of 5000 cells per well. The following day, cells
were treated with different concentrations of melatonin
and 20% (v/v) DMSO. Cell viability was measured by the
MTS assay (CellTiter96 Aqueous One Solution, Promega,
UK) according to the manufacturer’s instructions. MTS
(3-(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxy-methoxyphenyl)-2-(4-sulfo-phenyl)-2H-tetrazolium) is a yellow
tetrazolium salt that is catabolized to formazan by
dehydrogenase enzyme in mitochondria of living cells.
Formazan is a purple compound and the detection in
this assay is based on the measurement of formazan
compounds by an ELISA plate reader. After incubating the
cells with melatonin for 24, 48, and 72 h, 10 µL of MTS
reagent and 100 µL of DMEM were added to the cells
followed by incubation for 2 h. Thereafter, the absorbance
at 490 nm was measured by an ELISA plate reader (BioTek
Instruments, Inc., USA).
2.4. Differentiation process
hTGSCs were induced to differentiate into osteogenic,
neurogenic, adipogenic, chondrogenic, odontogenic, and
myogenic cells. The cells were seeded on a six-well plate
for RNA isolation and a 48-well plate (BIOFIL, TCP) for
immunocytochemistry at a density of 150,000 cells/well
and 10,000 cells/well respectively for each differentiation.
For osteogenic differentiation the cells were seeded on
six-well plates followed by the addition of osteogenic
differentiation medium, which consisted of DMEM, 10%
(v/v) FBS, 0.1 µM dexamethasone (AppliChem, Germany),
10 mM β-glycerol phosphate (Sigma, USA), and 50 µg/mL
ascorbic acid (Sigma) (Taşlı et al., 2013a), with or without
100 nM melatonin. The medium was changed every
other day and the cells were treated with the osteogenic
differentiation medium for 14 days. For adipogenic
differentiation, the cells were induced to differentiate into
adipocytes using a previously published method (Lu et al.,
2009). The cells were seeded on a six-well plate and given
adipogenic differentiation medium, which is composed
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of DMEM, 10% (v/v) FBS, 1 µM dexamethasone, 100 µM
indomethacin (Sigma), 500 µM IBMX (Calbiochem, Merck
Millipore, Germany), and 0.01 mg/mL insulin (GIBCO),
with or without melatonin. Adipogenic differentiation
lasted 10 days in the adipogenic differentiation medium
that was changed every other day. In the neurogenic
differentiation experiments, a modification of a previously
published method was used for neural induction. hTGSCs
were treated with a medium including DMEM, 10% (v/v)
FBS, 200 µM butylated hydroxyanisole (Sigma), 5 mM
KCl, 2 µM valproic acid (Sigma), and 5 g/mL insulin for
14 days with the medium changed every 3 days, with
or without melatonin. A modification of a previous
method was used for chondrogenic differentiation. The
chondrogenic differentiation medium consisted of DMEM
supplemented with 10% (v/v) FBS, 0.1 µM dexamethasone,
10 ng/mL TGF-β1 (Sigma), 50 mg/mL ITS (GIBCO),
5.35 mg/mL linoleic acid (Acros Organics, Belgium),
and 6.25 µg/mL insulin, with or without melatonin.
The chondrogenic differentiation lasted for 3 weeks,
changing the medium every 2–3 days. The odontogenic
differentiation was conducted by treating the cells with
differentiation medium containing DMEM, 10% (v/v)
FBS, 10–8 M dexamethasone, 5 mmol/L KH2PO4, and 50
µg/mL ascorbic acid, with or without melatonin (Taşlı et
al., 2013a). Eventually, myogenic differentiation was done
with DMEM medium supplemented with 5% (v/v) horse
serum, 0.1 µM dexamethasone, and 50 µM hydrocortisone
(Sigma) (Taşlı et al., 2013b). The myogenic differentiation
took 3 weeks with medium changed every 2–3 days.
Positive control groups were treated with the respective
differentiation mediums while negative control groups
were cultured only in DMEM supplemented with 10%
(v/v) FBS and 1% (v/v) PSA.
2.5. Alkaline phosphatase activity assay
Alkaline phosphatase (ALP) activity was determined to
demonstrate osteogenic differentiation. After the process
of osteogenic differentiation, medium was removed and
cells were treated with 0.2% (w/v) Triton X-100 (BioBasic
Inc., Canada) for lysis. Cells were collected from plates
and mixed by vortex for 20 min at room temperature.
Thereafter, 10 µL of cell lysate was added to each well of
a 96-well plate followed by the addition of 90 µL of ALP
solution (BioAssay Systems, USA). After incubation for 15
min, the absorbance at 405 nm was measured by an ELISA
plate reader.
2.6. Von Kossa staining
Von Kossa staining is a method based on the detection
of calcium or calcium salt deposits. Cells were seeded
on six-well plates at a concentration of 50,000 cells/
well. At the end of both osteogenic and odontogenic
differentiation, the medium was removed and the cells
were washed three times with PBS. The cells were then
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incubated with paraformaldehyde for 20 min for fixation.
After the addition of 3% (w/v) silver nitrate, the cells were
exposed to UV light for 1 h at room temperature. After
washing the cells three times with PBS, 5% (w/v) sodium
thiosulfate was added to each well followed by incubation
for 2 min at room temperature. After the incubation, the
cells were again rinsed three times with PBS. Thereafter,
the cells were incubated with nuclear fast red for 5 min at
room temperature. After washing with PBS, the cells were
observed under a light microscope (Güven et al., 2013).
2.7. Oil red O staining
Oil red oil solution was prepared by dissolving 0.5 g of oil
red oil (Sigma, USA) in 100 mL of isopropanol. The cells
were then fixed with 2% (w/v) paraformaldehyde for 30
min followed by washing three times with PBS. The cells
were then incubated with oil red oil solution diluted 6:4 in
PBS for 1 h for staining. Cells were washed with PBS and
observed under a light microscope (Doğan et al., 2012).
2.8. Alcian blue staining
One gram of alcian blue dye (Sigma) was dissolved in
100 mL of 3% (w/v) acetic acid to prepare the alcian
blue staining solution. The cells were fixed with 2%
paraformaldehyde for 30 min and incubated with alcian
blue staining solution for 30 min. After the incubation, the
cells were washed three times with PBS and the samples
were observed under a light microscope (Taşlı et al.,
2013c).
2.9. Immunocytochemistry
At the end of the differentiation procedures of hTGSCs,
the cells were incubated with 2% (w/v) paraformaldehyde
for 30 min at 4 °C for fixation. The cells were washed
with PBS three times for 5 min by shaking the plates on
a plate shaker. Later on, the cells were permeabilized by
incubation with 0.1% (v/v) Triton X-100 (in PBS) for 5
min at room temperature followed by washing three times
for 5 min with PBS. The cells were incubated with 2%
(v/v) goat serum (Sigma) for 20 min at 4 °C for preventing
nonspecific binding of primary antibodies. The cells
were again washed three times with PBS. The cells were
incubated overnight with primary antibodies at 4 °C.
For osteogenic differentiation collagen type 1 (COL1A;
Abcam, UK) and osteocalcin (Santa Cruz Biotechnology);
for neurogenic differentiation enolase (Santa Cruz
Biotechnology), nestin (Santa Cruz Biotechnology),
neurofilament (NF; Santa Cruz Biotechnology), and
tyrosine hydroxylase (TH; Santa Cruz Biotechnology);
for adipogenic differentiation adipocyte protein 2 (αP2;
Santa Cruz Biotechnology) and PPAR-γ (Abcam); for
chondrogenic differentiation collagen type 2 (COL2A;
Abcam); for myogenic differentiation actin (Santa Cruz
Biotechnology), α-smooth muscle actin (α-SMA; Abcam),
desmin (Abcam), and MyoD (Santa Cruz Biotechnology);
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and for odontogenic differentiation COL1A and dentin
sialoprotein (DSP) (Santa Cruz Biotechnology) were used.
The cells were washed three times with PBS to remove
excess antibody after incubating with primary antibodies.
Thereafter, the cells were treated with secondary antibodies
(goat antirabbit IgG Alexa Fluor 488, goat antimouse IgG
Alexa Fluor 488) and incubated for 1 h at 4 °C followed by
rinsing three times with PBS. DAPI (AppliChem) was used
to stain the nuclei of the cells by incubating for 20 min at
4 °C. The cells were then rinsed three times with PBS and
observed under a fluorescence microscope (Nikon Eclipse
TE200).
2.10. Quantitative real-time PCR
Total RNA isolation after differentiation was performed
using a High Pure RNA Isolation Kit (Roche, Germany)
according to the manufacturer’s instructions. cDNA
synthesis from isolated RNA samples was done using a
High Fidelity cDNA Synthesis Kit (Roche). Real-time
PCR was performed using Maxima SYBR Green/ROX
(Fermentas, USA) for the determination of expression
levels of differentiation-related genes after differentiations
(Table). cDNAs of the differentiated cells incubated with

or without melatonin were used as templates and were
mixed with primers and Maxima SYBR Green/ROX
qPCR Master Mix (2X). Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as the house-keeping
gene for the normalization of the data. All the real-time
PCR experiments were performed using the iCycler RTPCR detection system (Bio-Rad, USA).
2.11. Statistical analysis
All data are shown as the means ± standard errors. Graphics
were drawn using GraphPad Prism 5 software. The results
of real-time PCR data were normalized to the mRNA level
of GAPDH. The statistical analysis of the results were
performed by one-way ANOVA followed by the multiplecomparison Tukey test using GraphPad Prism 5 software.
Statistical significance was determined at P < 0.05.
3. Results
Human tooth germ stem cells were characterized for
the surface antigens CD29, CD34, CD45, CD73, CD90,
CD105, CD133, and CD166 by flow cytometry. Cells were
positive for CD29, CD73, CD90, CD105, and CD166,
whereas they were negative for CD34, CD45, and CD133

Table. Primers used in this study quantitative in real-time PCR.
Marker

Sequences (5’-3’)

References

Osteocalcin

GTGCAGAGTCCAGCAAAGGT

Taşlı et al., 2013a

TCAGCCAACTCGTCACAGTC
ALP

GACATCGCCTACCAGCTCAT
TCACGTTGTTCCTGTTCAGC

Nestin

GGAGTCCTGGATTTCCTTCC
GCCCTGACCACTCCAGTTTA

CD133

GCCAGCCTCAGACAGAAAAC
CCAAGCCTTAGGAGCATCTG

MAP2

CCATTTGCAACAGGAAGACAC
CAGCTCAAATGCTTTGCAACTAT

Adiponectin

TATCCCCAACATGCCCATTCG

Borges-Silva et al., 2005

TGGTAGGCAAAGTAGTACAGCC
PPAR-γ

CCTATTGACCCAGAAAGCGATT

Borges-Silva et al., 2005

CATTACGGAGAGATCCACGGA
LPL

ACAAGAGAGAACCAGACTCCAA

Borges-Silva et al., 2005

AGGGTAGTTAAACTCCTCCTCC
αP2

AACCTTAGATGGGGGTGTCCT

Borges-Silva et al., 2005

TCGTGGAAGTGACGCCTTTC
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Table. (Continued).
Marker

Sequences (5’-3’)

Sox 9

GAACGCACATCAAGACGGAG

References

TCTCGTTGATTTCGCTGCTC
Aggrecan

ACTGCTGCAGACCAGGAGGT
TCCTCGGGGGTGACGATGCT

COL2A

GTGTGGAAGCCGGAGCCCTG

Taşlı et al., 2013b

GGTCCTGGTTGCCCACTGGC
DSPP

CAGTACAGGATGAGTTAAATGCC
TACTTCTGCCCACTTAGAGCC

COL1A

CCACGCATGAGCGGACCCTAA
ATTGGTGGGATGTCTTCGTCTTGG

BMP 2

CCACCATGAAGAATCTTTGGAAGA
ATTAAGCCACTACCTTTGACGATAAC

Desmin

GGAGAGCCGGATCAATCTCCCCA
ACGACCTCCCCATCCCGTGT

Myogenin

TAAGGTGTGTAAGAGGAAGTCG
CCACAGACACATCTTCCACTGT

ACTA 2

AGACATCAGGGGGTGATGGT
ATCTTTTCCATGTCGTCCCAGTTG

MyoD

AAGCGCCATCTCTTGAGGTA

Taşlı et al., 2015

GCGCCTTTATTTTGACC
GAPDH

TGGTATCGTGGAAGGACTCA
GCAGGGATGATGTTCTGGA

ALP: Alkaline phosphatase, CD133: cluster of differentiation 133, MAP2: microtubule-associated protein 2, PPAR-γ: peroxisome
proliferator-activated receptor gamma, LPL: lipoprotein lipase, αP2: adipocyte protein 2, COL2A: collagen type 2, DSPP: dentin
sialophosphoprotein, COL1A: collagen type 1, ACTA 2: alpha-actin-2(α-SMA), MyoD: myogenic differentiation 1, GAPDH:
glyceraldehyde 3-phosphate dehydrogenase.

(Figure 1a). These data showed that hTGSCs were positive
for MSC markers and negative for HSC markers. Toxicity
of melatonin was measured by MTS assay at various
concentrations (50 nM, 100 nM, 150 nM) for days 1, 2,
and 3. The results showed that melatonin was toxic to
hTGSCs at none of the concentrations tested (Figure 1b).
On the contrary, it significantly increased the survival of
cells at each concentration on each day compared to the
negative control, except 100 nM melatonin on the 3rd
day. Melatonin at 50 nM increased the survival of cells by
120%, 125%, and 110% at days 1, 2, and 3, respectively. For
100 nM melatonin, the survival rate of cells was increased
by 125%, 122%, and 132% at days 1, 2, and 3, respectively.
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Finally, 150 nM melatonin raised the survival by 119%,
130%, and 110% at days 1, 2, and 3, respectively (Figure
1b). They also expressed the two melatonin receptors,
melatonin receptor 1 A (MTNR1A) and melatonin
receptor 1 B (MTNR1B) (Figure 1c).
Osteogenic differentiation of hTGSCs was confirmed
by von Kossa staining, immunocytochemistry, ALP
activity, and quantitative real-time PCR. Von Kossa
staining is a standard method to show calcium or calcium
salt deposits as an indicator of osteogenic differentiation.
Calcium depositions were detected by this method in
cells treated with melatonin as well as in the positive
control, demonstrating the osteogenic differentiation
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Figure 1. (a) Flow cytometry analysis of hTGSCs. (b) Toxicity results of different concentrations of melatonin. (c) Melatonin receptors
on hTGSCs. Scale bars 100 and 400 µm. NC: Negative control. *P < 0.05 versus the negative control.

(Figure 2a). The expressions of osteocalcin and COL1A
were visualized by immunocytochemistry. The data
showed that expressions of osteocalcin and COL1A were
upregulated in melatonin compared with positive control
groups, whereas there was no expression in the negative
control (Figure 2b). ALP activity was measured for the
determination of osteogenic differentiation (Figure 2c).
mRNA levels showed that cells treated with melatonin had
the highest expression levels of these genes. Furthermore,
mRNA levels of the marker genes were higher in the
positive control compared to the negative control group
(Figure 2d). The expression levels of osteocalcin, ALP,
and COL1A were detected significantly higher than in the
positive control in the melatonin group.
Immunocytochemistry assay was performed for
neuron-specific enolase (NSE), nestin, NF, and TH (Figure
3a). The melatonin group and the positive control were
positively stained for NSE, nestin, NF, and TH, whereas
the negative control did not show expressions of these
marker genes. The real-time PCR results showed that the

melatonin-treated group expressed the highest mRNA
levels of CD133, nestin, and MAP2 compared to positive
and negative controls (Figure 3b).
For adipogenic differentiation, the expression of αP2
and PPAR-γ was checked by immunocytochemistry.
Melatonin downregulated the expression of these two
markers and gave a similar result to those of the negative
control, while the positive control groups exhibited
higher expressions of αP2 and PPAR-γ (Figure 4a). Oil
red oil is a lysochrome diazo dye used to stain lipids and
neutral triglycerides. Oil red oil staining was performed
to visualize the intracellular lipid vesicles after adipogenic
differentiation. Lipid vesicles were detected only in the
positive control (Figure 4b). Expression levels of markers
for terminal adipocyte differentiation, such as adiponectin,
lipoprotein lipase (LPL), αP2, and PPAR-γ, were detected
by real-time PCR. Cells treated with melatonin during
adipogenic differentiation showed the lowest mRNA
expressions of the all marker genes compared to positive
control groups (Figure 4c).
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Figure 2. (a) Von Kossa staining of melatonin, PC, and NC. Scale bar: 400 µm. (b) Immunostaining of COL1A and osteocalcin in
melatonin and control groups. Scale bar: 100 µm. (c) ALP activity results of melatonin and control groups. (d) Osteocalcin, ALP, and
COL1A expressions in melatonin and control groups. Mel: Melatonin, PC: positive control, NC: negative control. *P < 0.05 versus the
PC, # P < 0.05 versus the NC.

COL2A is the main protein of articular and hyaline
cartilage tissues. Expression of COL2A was checked with
immunocytochemistry. Results showed that melatonin
and positive control groups were positively stained,
whereas the negative control showed almost no expression
of COL2A (Figure 5a). Alcian blue staining was done
for the confirmation of chondrogenic differentiation.
The melatonin group showed the highest amount of
mucopolysaccharides and glycosaminoglycans formed in
cells (Figures 5b and 5c). mRNA levels of Sox 9, aggrecan,
and COL2A were detected by real-time PCR. Melatonin
groups had much higher mRNA levels of Sox 9, aggrecan,
and collagen II than the positive control (Figure 5d).
Actin, α-SMA, desmin, and MyoD were immunostained
for the confirmation of myogenic differentiation of
hTGSCs. Immunocytochemistry results indicate that
both the melatonin group and the positive control were
positively stained for actin, α-SMA, desmin, and MyoD,
demonstrating the myogenic differentiation of the cells.
However, the negative control showed lower expression
levels of these marker genes (Figure 6a). The myogenic
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markers were analyzed by real-time PCR for their
expression levels to confirm the myogenic differentiation.
The results indicate that all of the four marker genes were
highly expressed in the melatonin groups (Figure 6b).
The von Kossa staining method was performed to visualize
the calcium deposits after odontogenic differentiation.
Differentiated cells treated with melatonin as well as the
positive control were positively stained, whereas the negative
control did not give any positive results (Figure 7a). COL1A
and DSP were checked by immunocytochemistry to confirm
the odontogenic differentiation. The melatonin group and
positive control showed positive results for COL1A and DSP,
whereas the negative control did not exhibit any expressions
for these marker genes (Figure 7b). ALP activity was measured
for the determination of odontogenic differentiation (Figure
7c). For odontogenic differentiation, DSPP, COL1A, and
BMP-2 were chosen as marker genes and mRNA expression
levels were detected by real-time PCR. Melatonin upregulated
the mRNA expression of DSPP by 1.6-fold, COL1A by 2-fold,
and BMP-2 by 2.2-fold compared to the positive control
(Figure 7d).
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Figure 3. (a) Immunostaining of NSE, nestin, NF, and TH. Scale bar: 100 µm. (b) CD133, nestin, and MAP2 gene expressions of
melatonin and control groups. Mel: Melatonin, PC: positive control, NC: negative control. *P < 0.05 versus the PC, # P < 0.05 versus
the NC.

4. Discussion
The term “regenerative medicine” was first used by William
A Haseltine in 2000 to describe biomedical approaches
involving the replacement or regeneration of cells. Stem
cells are a good candidate for regenerative medicine
because of their great proliferation and differentiation
capacity (Bianco and Robey, 2001). The source of stem
cells is of great importance and is one of the major issues
to be addressed since adequate numbers of stem cell are
required for therapeutic use. The ideal situation is to find
a source of stem cells in sufficient numbers and with
high proliferation and differentiation ability as well as
being easy to isolate from the body without any risk for
the patient or long culture procedures. Researchers have
characterized various tissues possessing stem cells with
mesenchymal stem cell properties since bone marrow
was identified as the first mesenchymal stem cell source

(Friedenstein et al., 1976). Bone marrow mesenchymal
stem cells can be easily isolated and cultured in vitro.
However, surgical procedures are required for the
isolation of these cells; therefore, it has potential risks of
contamination. The isolation procedure is traumatic and
the number of cells obtained is limited (Campagnoli et
al., 2001). Moreover, bone marrow-related disorders are
another problem for this procedure. Dental tissue seems
to be a good candidate as an alternative stem cell source.
Dental stem cells (DSCs) among others are more easily
isolated with simple surgical access and cultivated. They
are also mostly waste materials of dental procedures.
Furthermore, they do not cause ethical controversies.
Low morbidity in the collecting site after surgical
attempts is another advantage of DSCs (Yalvac et al.,
2010). DSCs were proven to be converted to different
lineages including osteogenic, odontogenic, adipogenic,
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Figure 4. (a) Immunocytochemistry results of αP2 and PPAR-γ. Scale bar: 100 µm. (b) Oil red oil staining of melatonin, PC and NC.
Scale bar: 100 µm. (c) Adiponectin, LPL, αP2, and PPAR-γ gene expressions in melatonin and control groups. Mel: Melatonin, PC:
positive control, NC: negative control. *P < 0.05 versus the PC, # P < 0.05 versus the NC.

and neurogenic cells and were used in some preclinical
applications (Gronthos et al., 2000).
In the current study, we used hTGSCs obtained
from human third molars (wisdom teeth), which show
mesenchymal stem cell characteristics, and we tested
the effect of melatonin on differentiation of these cells
into osteogenic, neurogenic, adipogenic, chondrogenic,
myogenic, and odontogenic cells. Scientists have
demonstrated that melatonin regulates the differentiation
efficiency of mesenchymal stem cells. Melatonin
increases osteogenic differentiation in human and mouse
mesenchymal stem cells and stimulates neurogenesis in
mice, whereas it suppresses the adipogenic differentiation
of human mesenchymal stem cells. We chose a nontoxic
concentration (50 nM) of melatonin to use in the
differentiation experiments. Melatonin’s effect on
osteogenic differentiation of hTGSCs and the data on
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osteocalcin, ALP, and COL1A mRNA levels by real-time
PCR and COL1A and osteocalcin immunostaining were
investigated. Furthermore, von Kossa staining and ALP
activity assays were performed. All the data from these
experiments demonstrate that osteogenic differentiation of
hTGSCs was increased by melatonin induction. This result
shows similarity to a previous study in which melatonin
raised the osteogenic differentiation ability of human
mesenchymal stem cells. Neurogenic differentiation of
hTGSCs was confirmed by real-time PCR analysis for
neurogenic markers CD133, nestin, and MAP2, as well
as TH, enolase, nestin, and MAP2 immunostaining.
Melatonin was previously proven to upregulate the
expression of neurogenic markers such as NeuroD1.
In another study, it was demonstrated that melatonin
increased neurogenic differentiation of neural stem cells
when it was administered during the proliferation period,
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Figure 5. (a) Alcian blue staining of melatonin and control groups. (b) General view of stained wells. Scale bar: 400 µm. (c)
Immunostaining of COL2A. Scale bar: 100 µm. (d) Sox 9, aggrecan, and COL2A expressions in melatonin and control groups. Mel:
Melatonin, PC: positive control, NC: negative control. *P < 0.05 versus the PC, # P < 0.05 versus the NC.

although it decreased neurogenic differentiation in the
case of administration during the differentiation period.
In contrast to this result, we showed that the neurogenic
commitment of hTGSCs was elevated by melatonin when
they were treated during the differentiation process.
Adipogenic differentiation of hTGSCs was confirmed by
the detection of mRNA levels of adiponectin, LPL, αP2,
and PPAR-γ, as well as αP2 and PPAR-γ immunostaining.
Lipid formation was decreased by melatonin in the
melatonin group compared to the positive control. These
results, including the immunocytochemical data, prove
that melatonin reduces adipogenic differentiation of
hTGSCs. These results are similar to a previous study in
which the adipogenic conversion of mesenchymal stem
cells were inhibited by melatonin treatment.
Chondrogenic differentiation was confirmed by realtime PCR analysis of Sox 9, aggrecan, and COL2A as well as

immunocytochemistry for COL2A. Chondrogenic results
prove that melatonin also increases the chondrogenic
differentiation of hTGSCs. Melatonin was also tested
for its effect on the myogenic differentiation of hTGSCs.
Although melatonin is discovered to enhance the survival
of myocytes, it is still unclear whether it has a potential
effect on the myogenic differentiation of mesenchymal
stem cells. In this study, we show that it raises the myogenic
conversion of hTGSCs, which have mesenchymal stem
cell properties. Finally, odontogenic differentiation was
determined by measuring mRNA levels of DSPP, COL1A,
and BMP-2 by real-time PCR analysis, immunostaining
of COL1A and DSP, and von Kossa staining to observe
calcium depositions. It was concluded that melatonin also
raised odontogenic efficiency of hTGSCs. For the first
time, melatonin’s effect on odontogenic differentiation was
shown in this study.
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Figure 6. (a) Immunostaining of actin, α-SMA, desmin, and MyoD. Scale bar: 100 µm. (b) Myogenin, MyoD, desmin, and ACTA2 gene
expressions. Mel: Melatonin, PC: positive control, NC: negative control. *P < 0.05 versus the PC, # P < 0.05 versus the NC.

In conclusion, melatonin increased osteogenic,
neurogenic, chondrogenic, myogenic, and odontogenic
differentiation of hTGSCs, whereas it inhibited
adipogenic differentiation. The osteogenic and adipogenic
differentiation of mesenchymal stem cells are dependent on
certain lineage-specific transcription factors. These factors
determine whether cells will enter bone or fat cell lineages.
PPAR-γ and the CCAAT/enhancer-binding protein (C/
EBP) family regulate adipogenic differentiation while
Runx2 and osterix regulate osteogenic differentiation.
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The relationship between PPAR-γ and Runx2 is crucial
for leading mesenchymal stem cells to osteogenic or
adipogenic commitment. It has been shown that the high
expression of PPAR-γ decreases the expression of Runx2
while low expression of PPAR-γ decreases adipogenesis
and increase osteogenesis.
In our study, it was found that PPAR-γ was
downregulated in the treatment of melatonin. However,
Runx2 expression in differentiated hTGSCs is also
needed to be investigated to better understand whether
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Figure 7. (a) Von Kossa staining of melatonin, PC, and NC. Scale bar: 400 µm. (b) COL1A and DSP immunocytochemistry results.
Scale bar: 100 µm. (c) ALP activity results of melatonin and control groups. (d) DSPP, COL1A, and BMP-2 expressions in melatonin and
control groups. Mel: Melatonin, PC: positive control, NC: negative control. *P < 0.05 versus the PC, # P < 0.05 versus the NC.

there is the same regulation system between Runx2
and PPAR-γ. The relationship between osteogenic and
adipogenic determination is especially important for
osteoporosis, in which bone formation is accompanied
by elevated adipogenesis in bone marrow. Based on our
results, melatonin might be a good candidate as a drug
for preventing osteoporosis. Besides its various roles
in the human body, the use of melatonin increases the
possibility of success in regenerative therapy applications
since it increases the survival of cells as well as supports
the differentiation of them. Moreover, hTGSCs are a good

stem cell source for a number of reasons, such as having
mesenchymal stem cell properties, being a waste material
with no contamination risk, causing no ethical issues,
and having an easy isolation procedure. In this study,
we found that melatonin increases the differentiation
abilities of hTGSCs. In the future, it might be possible to
use melatonin as a drug due to its promoting effects on
stem cells for the treatment of many disorders involving
cell or tissue damage such as neurodegenerative diseases,
degenerative muscle diseases, diabetes, and osteoporosis.
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